Total body irradiation and cyclophosphamide is a conditioning regimen for unrelated bone marrow transplantation in a patient with chronic myelogenous leukemia and renal failure on hemodialysis

被引:13
|
作者
Bischoff, ME
Blau, W
Wagner, T
Wagenmann, W
Dörner, O
Basara, N
Fauser, AA
机构
[1] Dept Hematol Oncol & Bone Marrow Transplantat, D-55743 Idar Oberstein, Germany
[2] Univ Lubeck, Dept Internal Med, Div Hematol Oncol, D-2400 Lubeck, Germany
[3] Univ Mainz, Sch Med, Hosp Idar Oberstein, Dept Radiol, D-6500 Mainz, Germany
[4] Univ Mainz, Sch Med, Hosp Idar Oberstein, Dept Internal Med, D-6500 Mainz, Germany
关键词
bone marrow transplantation; renal failure; cyclophosphamide; total body irradiation; pharmacokinetics; hemodialysis;
D O I
10.1038/sj.bmt.1701380
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Five years after the diagnosis of Ph chromosome-positive chronic myeloid leukemia (CML) a 31-year-old patient developed malignant nephrosclerosis with renal failure. He then underwent an allogeneic unrelated BMT in first chronic phase CML. The preparative regimen consisted of fractionated total body irradiation (TBI) and cyclophosphamide (CY), We studied the pharmacokinetics of cyclophosphamide on hemodialysis and compared clinical parameters including time to engraftment and toxicity with parameters of a patient with normal renal function who also received an unrelated marrow as treatment for CML in first chronic phase. Our results suggest that TBI/CY is a suitable conditioning regimen for allogeneic transplantation in patients with hematological malignancy and renal failure on hemodialysis.
引用
收藏
页码:591 / 593
页数:3
相关论文
共 50 条
  • [1] Total body irradiation and cyclophosphamide is a conditioning regimen for unrelated bone marrow transplantation in a patient with chronic myelogenous leukemia and renal failure on hemodialysis
    ME Bischoff
    W Blau
    T Wagner
    W Wagenmann
    O Dörner
    N Basara
    AA Fauser
    Bone Marrow Transplantation, 1998, 22 : 591 - 593
  • [2] PIPERAZINEDIONE AND TOTAL-BODY IRRADIATION (TBI) AS CONDITIONING REGIMEN FOR BONE-MARROW TRANSPLANTATION IN CHRONIC MYELOGENOUS LEUKEMIA (CML)
    VELLEKOOP, L
    ZANDER, AR
    DICKE, KA
    VERMA, DS
    JAGANNATH, S
    SPITZER, G
    FREIREICH, EJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 190 - 190
  • [3] Busulfan, cyclophosphamide and total body irradiation as conditioning for allogeneic bone marrow transplantation for acute and chronic myeloid leukemia
    Hirabayashi, N
    Goto, S
    Ishii, M
    Yuge, M
    Mitsuma, A
    Noda, N
    BONE MARROW TRANSPLANTATION, 1998, 21 (11) : 1079 - 1083
  • [4] Busulfan, cyclophosphamide and total body irradiation as conditioning for allogeneic bone marrow transplantation for acute and chronic myeloid leukemia
    N Hirabayashi
    S Goto
    M Ishii
    M Yuge
    A Mitsuma
    N Noda
    Bone Marrow Transplantation, 1998, 21 : 1079 - 1083
  • [5] BUSULFAN AND CYCLOPHOSPHAMIDE VERSUS CYCLOPHOSPHAMIDE AND TOTAL-BODY IRRADIATION FOR MARROW TRANSPLANTATION IN CHRONIC MYELOGENOUS LEUKEMIA - A REVIEW
    SANTOS, GW
    LEUKEMIA & LYMPHOMA, 1993, 11 : 201 - 204
  • [6] Bone marrow transplantation in patients with Fanconi anemia: Experience with cyclophosphamide and total body irradiation conditioning regimen
    Solh, H
    Rao, K
    daCunha, AM
    Padmos, A
    Sackey, K
    Ernst, P
    Spence, D
    Clink, H
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1997, 14 (01) : 67 - 72
  • [7] HYPERFRACTIONATED TOTAL-BODY IRRADIATION IN ADDITION TO CYCLOPHOSPHAMIDE AS CONDITIONING REGIMEN FOR MARROW TRANSPLANTATION
    PETERSEN, FB
    BUCKNER, CD
    APPELBAUM, FR
    THOMAS, ED
    EXPERIMENTAL HEMATOLOGY, 1988, 16 (06) : 493 - 493
  • [8] Total body irradiation, busulfan and cyclophosphamide as a conditioning regimen for allogeneic bone marrow transplantation for patients with hematological malignancies
    Kai, S
    Misawa, M
    Hara, H
    JAPANESE JOURNAL OF TRANSPLANTATION, 1999, 34 (04) : 191 - 199
  • [9] PIPERAZINEDIONE, TOTAL-BODY IRRADIATION, AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN CHRONIC MYELOGENOUS LEUKEMIA
    VELLEKOOP, L
    ZANDER, AR
    KANTARJIAN, HM
    JAGANNATH, S
    HESTER, JP
    TRUJILLO, J
    MCCREDIE, KB
    ZAGARS, G
    SPITZER, G
    DICKE, KA
    JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (06) : 906 - 911
  • [10] Unrelated-donor bone marrow transplantation with a conditioning regimen including fludarabine, busulfan, and 4 Gy total body irradiation
    Onishi, Yasushi
    Mori, Shin-ichiro
    Kusumoto, Shigeru
    Sugimoto, Kyoko
    Akahane, Daigo
    Morita-Hoshi, Yuriko
    Kim, Sung-Won
    Fukuda, Takahiro
    Heike, Yuji
    Tanosaki, Ryuji
    Tobinai, Kensei
    Takaue, Yoichi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2007, 85 (03) : 256 - 263